JSB Market Research : Hepatitis C - Pipeline Review, H1 2015
Hepatitis C Pipeline Review, H1 2015′, provides an overview of the Hepatitis C’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Hepatitis C, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis C and special features on late-stage and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
The report Hepatitis C - Pipeline Review, H1 2015 provides a snapshot of the global therapeutic landscape of Hepatitis C
The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved in the therapeutics development for Hepatitis C and enlists all their major and minor projects
The report summarizes all the dormant and discontinued pipeline projects
A review of the Hepatitis C products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
Pipeline products coverage based on various stages of development ranging from per-registration till discovery and undisclosed stages
A detailed assessment of mono therapy and combination therapy pipeline projects
Coverage of the Hepatitis C pipeline on the basis of target, MoA, route of administration and molecule type
Latest news and deals relating related to pipeline products
Reasons to buy
Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop strategic initiatives by understanding the focus areas of leading companies
Identify and understand important and diverse types of therapeutics under development for Hepatitis C
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Devise corrective measures for pipeline projects by understanding Hepatitis C pipeline depth and focus of Indication therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Browse Full Report@ http://www.jsbmarketresearch.com/healthcare-medical/r-hepatitis-c-pipeline-review-h1-2015-178257
Table of Contents
List of Tables 12
List of Figures 16
Introduction 17
Global Markets Direct Report Coverage 17
Hepatitis C Overview 18
Therapeutics Development 19
Pipeline Products for Hepatitis C - Overview 19
Pipeline Products for Hepatitis C - Comparative Analysis 20
Hepatitis C - Therapeutics under Development by Companies 21
Hepatitis C - Therapeutics under Investigation by Universities/Institutes 30
Hepatitis C - Pipeline Products Glance 33
Late Stage Products 33
Clinical Stage Products 34
Early Stage Products 35
Unknown Stage Products 36
Hepatitis C - Products under Development by Companies 37
Hepatitis C - Products under Investigation by Universities/Institutes 52
For More Related Market Research Reports click here:
Pulmonary Fibrosis - Pipeline Review, H1 2015
Hepatitis A - Pipeline Review, H1 2014
Healthcare and Medical Market Research
About JSB Market Research -
JSB Market Research is one of the most significant databases of online market researches and intelligence reports and services. We specialize in providing market research reports for various industries. The online portal for marketing research deals with access to global market data and assists in providing expert insights and exposure on global companies, industries, products and trends.
Contact –
Phone: +91 - 998 729 5242
Website: http://www.jsbmarketresearch.com
Email - contact@jsbmarketresearch.com